Overview

Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures

Status:
Completed
Trial end date:
2017-04-19
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the efficacy of lusutrombopag with placebo for the treatment of thrombocytopenia in patients with chronic liver disease who are undergoing elective invasive procedures.
Phase:
Phase 3
Details
Lead Sponsor:
Shionogi